FAACT-Anorexia Cachexia Scale: Cutoff Value for Anorexia Diagnosis in Advanced Non-Small Cell Lung Cancer Patients

被引:10
作者
Georgina Turcott, Jenny [1 ]
Onate-Ocana, Luis F. [2 ]
Soca-Chafre, Giovanny [3 ]
Ramirez-Tirado, Laura-Alejandra [3 ]
Flores-Estrada, Diana [1 ]
Lucia Zatarain-Barron, Zyanya [1 ]
Arrieta, Oscar [1 ]
机构
[1] Natl Canc Inst Mexico INCan, Thorac Oncol Unit, Mexico City, DF, Mexico
[2] Natl Canc Inst Mexico INCan, Div Surg, Clin Res Div, Mexico City, DF, Mexico
[3] Natl Canc Inst Mexico INCan, Expt Oncol Lab, Mexico City, DF, Mexico
来源
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | 2019年 / 71卷 / 03期
关键词
QUALITY-OF-LIFE; NUTRITIONAL-STATUS; ASSOCIATION; VALIDATION; ANAMORELIN; PROGNOSIS; THERAPY; DISEASE; IMPACT;
D O I
10.1080/01635581.2018.1506488
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung cancer (LC) has a high rate of anorexia, which negatively affects quality-of-life and prognosis; however prevalence values may vary as per diagnostic test. There is no standard for anorexia diagnosis, currently the anorexia cachexia scale (A/CS) has been proposed as a tool for diagnosing anorexia with a consensus cutoff value of <= 24, nonetheless a validated cutoff value is required. The A/CS was evaluated in advanced Non-Small Cell Lung Cancer (NSCLC) patients to establish a cutoff value. The appetite item from the QLQ-C30 questionnaire and survival served as a standard reference. The cutoff value was associated with clinical and nutritional characteristics along with quality-of-life. Three hundred and twelve (312) NSCLC patients were evaluated. The mean A/CS value was 31 +/- 9 and the identified cutoff value was 32.5 (sensitivity: 80.3% and specificity: 85%). The proportion of anorexia accurately diagnosed with the cutoff value of 24 was 26%, while with 32 it was 50%. The A/CS cutoff value of 32 was associated with clinical parameters, nutritional consumption, and quality-of-life, and independently associated with overall survival. A score of <= 32 in the A/CS is proposed for anorexia diagnosis in order to identify patients at risk of complications involving malnutrition related to LC.
引用
收藏
页码:409 / 417
页数:9
相关论文
共 50 条
  • [1] Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS)
    LeBlanc, Thomas W.
    Samsa, Greg P.
    Wolf, Steven P.
    Locke, Susan C.
    Cella, David F.
    Abernethy, Amy P.
    SUPPORTIVE CARE IN CANCER, 2015, 23 (08) : 2341 - 2347
  • [2] Quality of life and anorexia/cachexia in lung cancer: validation of the Spanish version of the FAACT instrument
    Arrieta, Oscar
    Luvian-Morales, Julissa
    Turcott, Jenny G.
    Onate-Ocana, Luis F.
    QUALITY OF LIFE RESEARCH, 2018, 27 (10) : 2709 - 2718
  • [3] Comprehensive validation of the functional assessment of anorexia/cachexia therapy (FAACT) anorexia/cachexia subscale (A/CS) in lung cancer patients with involuntary weight loss
    Gelhorn, Heather L.
    Gries, Katharine S.
    Speck, Rebecca M.
    Duus, Elizabeth M.
    Bourne, Richard K.
    Aggarwal, Dimple
    Cella, David
    QUALITY OF LIFE RESEARCH, 2019, 28 (06) : 1641 - 1653
  • [4] Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia
    Salsman, John M.
    Beaumont, Jennifer L.
    Wortman, Katy
    Yan, Ying
    Friend, John
    Cella, David
    SUPPORTIVE CARE IN CANCER, 2015, 23 (05) : 1355 - 1364
  • [5] Quality of life and anorexia/cachexia in lung cancer: validation of the Spanish version of the FAACT instrument
    Oscar Arrieta
    Julissa Luvián-Morales
    Jenny G. Turcott
    Luis F. Oñate-Ocaña
    Quality of Life Research, 2018, 27 : 2709 - 2718
  • [6] Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia
    John M. Salsman
    Jennifer L. Beaumont
    Katy Wortman
    Ying Yan
    John Friend
    David Cella
    Supportive Care in Cancer, 2015, 23 : 1355 - 1364
  • [7] Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer
    Kimura, Madoka
    Naito, Tateaki
    Kenmotsu, Hirotsugu
    Taira, Tetsuhiko
    Wakuda, Kazushige
    Oyakawa, Takuya
    Hisamatsu, Yasushi
    Tokito, Takaaki
    Imai, Hisao
    Akamatsu, Hiroaki
    Ono, Akira
    Kaira, Kyoichi
    Murakami, Haruyasu
    Endo, Masahiro
    Mori, Keita
    Takahashi, Toshiaki
    Yamamoto, Nobuyuki
    SUPPORTIVE CARE IN CANCER, 2015, 23 (06) : 1699 - 1708
  • [8] Correlation Between the International Consensus Definition of the Cancer Anorexia-Cachexia Syndrome (CACS) and Patient-Centered Outcomes in Advanced Non-Small Cell Lung Cancer
    LeBlanc, Thomas W.
    Nipp, Ryan D.
    Rushing, Christel N.
    Samsa, Greg P.
    Locke, Susan C.
    Kamal, Arif H.
    Cella, David F.
    Abernethy, Amy P.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2015, 49 (04) : 680 - 689
  • [9] Validation of the Chinese version of functional assessment of anorexia-cachexia therapy (FAACT) scale for measuring quality of life in cancer patients with cachexia
    Zhou, Ting
    Yang, Kaixiang
    Thapa, Sudip
    Fu, Qiang
    Jiang, Yongsheng
    Yu, Shiying
    SUPPORTIVE CARE IN CANCER, 2017, 25 (04) : 1183 - 1189
  • [10] Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study
    Takayama, Koichi
    Atagi, Shinji
    Imamura, Fumio
    Tanaka, Hiroshi
    Minato, Koichi
    Harada, Toshiyuki
    Katakami, Nobuyuki
    Yokoyama, Takuma
    Yoshimori, Kozo
    Takiguchi, Yuichi
    Hataji, Osamu
    Takeda, Yuichiro
    Aoe, Keisuke
    Kim, Young Hak
    Yokota, Soichiro
    Tabeta, Hiroshi
    Tomii, Keisuke
    Ohashi, Yasuo
    Eguchi, Kenji
    Watanabe, Koshiro
    SUPPORTIVE CARE IN CANCER, 2016, 24 (08) : 3473 - 3480